You are here
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Proposed standards for human blood and blood components, human tissues and human cellular therapy products
Closed on 2 February 2011
Closed on 27 August 2010
Proposed standards and Code of GMP for human blood and blood components, human tissues and human cellular therapies
Closed on 12 February 2010
Closed on 3 February 2006